Download full report with analyst certification and important disclosures
Feb 20 2025, 07:00 GMT
CRH’s ability to quickly scale its earnings – organically through the execution of its differentiated strategy, even as peers stagnate, and through disciplined M&A – remains a central pillar of the CRH investment case. Its multiple (11x EBITDA) suggests to us that it is also underappreciated relative to US peers.
Feb 20 2025, 07:00 GMT